The endocrine impact of long term risperidone therapy in Asian Indian patients

Journal Title: Open Journal of Psychiatry & Allied Sciences - Year 2017, Vol 8, Issue 2

Abstract

Background: Risperidone is a widely used antipsychotic, known to cause secondary hyperprolactinaemia. Related problems include bone mineral density (BMD) and vitamin D deficiency. However, there is insufficient information about the extent, severity, and association between these side effects, particularly in the Asian population. Objectives: To estimate the prevalence of osteoporosis, and vitamin D deficiency in patients taking risperidone for more than one year. Also, to investigate whether erectile dysfunction (ED) or menstrual dysfunction (MD) can be used as a proxy indicator of BMD loss in such patients, replacing dual energy X-ray absorptiometry (DEXA) scan. Method: Sixty-five patients (mean age 29.6) receiving risperidone as the only prolactin raising medication for minimum period of one year were selected taking into consideration the socio-demographic and clinical variables. History of ED/ MD, DEXA measurement of their lumbar and hip bone, and endocrine variables were recorded. Results: The prevalence of hyperprolactinaemia in female was found to be 84.4% and in males 78.8%; females being 1.4 times more at risk than males. Abnormal BMD was found in more than 40% of the subjects. Furthermore, 30% had vitamin D deficiency and 60.8% had vitamin D insufficiency. A statistically significant association was observed between ED/ MD and BMD (odds ration [OR] 3.71, confidence interval [CI] 1.23-11.24, p=0.02), but this varied according to the gender. Conclusion: These results suggest that patients on long term risperidone are at high risk of developing hyperprolactinaemia, reduced BMD and Vitamin D, although multiple contributory factors or mechanisms can be suggested. Clinically, ED was more significantly associated with changes in BMD.

Authors and Affiliations

JP Russell Ravan, Naveen Thomas, Thomas Paul, Samuel Prasanna, Nihal Thomas, Deepa Ramaswamy

Keywords

Related Articles

Methamphetamine: symptoms under the bridge

This case report discusses the abuse of methamphetamine in North East India.

Schizophrenia care: an overview considering family burden, medication adherence, and pharmacoeconomics

Schizophrenia is one of the leading causes of disability among all health problems. The discrimination and stigma are two unavoidable consequences of schizophrenia that individuals suffer most in developing countries. Ma...

A study of high risk behaviour among LGBT people of Manipur

Aim: Over the last two decades, there has been increasing demand for the awareness on sexual minority people’s lives and issues throughout the world. In the recent years, India is witnessing a change in public attitude a...

Gender differences among suspected suicide attempts in a rural tertiary care hospital on South India

Context: Globally, majority of suicide completers are known to be men as opposed to the majority of suicide attempters being women. Men use lethal methods more often than women who rely more on poisoning. Aims: To study...

Assessment of the effectiveness of yoga therapy as an adjunct in patients with alcohol dependence syndrome

Introduction: Substance use disorders, alcohol use in particular, are among the leading disorders in psychiatry in terms of prevalence. They put a lot of burden on health as well as family, society, and economic status o...

Download PDF file
  • EP ID EP183760
  • DOI 10.5958/2394-2061.2017.00003.9
  • Views 124
  • Downloads 0

How To Cite

JP Russell Ravan, Naveen Thomas, Thomas Paul, Samuel Prasanna, Nihal Thomas, Deepa Ramaswamy (2017). The endocrine impact of long term risperidone therapy in Asian Indian patients. Open Journal of Psychiatry & Allied Sciences, 8(2), 107-112. https://europub.co.uk/articles/-A-183760